IL-33 Boosts Anti-PD-L1 Therapy in Liver Cancer Models
A new study shows that IL-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-PD-L1 immunotherapy efficacy in hepatocellular carcinoma.
A new study shows that IL-33 alleviates the immunosuppressive tumor microenvironment and enhances anti-PD-L1 immunotherapy efficacy in hepatocellular carcinoma.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.